Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP170571.RAcnsrx0sRm7K7nkWqKvc-q6hU4K2VPDmrVWXydaQ3e38130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP170571.RAcnsrx0sRm7K7nkWqKvc-q6hU4K2VPDmrVWXydaQ3e38130_assertion type Assertion NP170571.RAcnsrx0sRm7K7nkWqKvc-q6hU4K2VPDmrVWXydaQ3e38130_head.
- NP170571.RAcnsrx0sRm7K7nkWqKvc-q6hU4K2VPDmrVWXydaQ3e38130_assertion description "[The prevalence of prothrombin (PT) G20210A and methylenetetrahydrofolate reductase (MTHFR) C677 <-- T was assessed in 40 patients with primary antiphospholipid syndrome (APS) (14 male, 26 female; mean age, 37 +/- 14 years) and in 27 persistent carriers of antiphospholipid antibodies (aPL) (five male, 22 female; mean age, 40 +/- 16 years) without underlying diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP170571.RAcnsrx0sRm7K7nkWqKvc-q6hU4K2VPDmrVWXydaQ3e38130_provenance.
- NP170571.RAcnsrx0sRm7K7nkWqKvc-q6hU4K2VPDmrVWXydaQ3e38130_assertion evidence source_evidence_literature NP170571.RAcnsrx0sRm7K7nkWqKvc-q6hU4K2VPDmrVWXydaQ3e38130_provenance.
- NP170571.RAcnsrx0sRm7K7nkWqKvc-q6hU4K2VPDmrVWXydaQ3e38130_assertion SIO_000772 11734671 NP170571.RAcnsrx0sRm7K7nkWqKvc-q6hU4K2VPDmrVWXydaQ3e38130_provenance.
- NP170571.RAcnsrx0sRm7K7nkWqKvc-q6hU4K2VPDmrVWXydaQ3e38130_assertion wasDerivedFrom befree-20140225 NP170571.RAcnsrx0sRm7K7nkWqKvc-q6hU4K2VPDmrVWXydaQ3e38130_provenance.
- NP170571.RAcnsrx0sRm7K7nkWqKvc-q6hU4K2VPDmrVWXydaQ3e38130_assertion wasGeneratedBy ECO_0000203 NP170571.RAcnsrx0sRm7K7nkWqKvc-q6hU4K2VPDmrVWXydaQ3e38130_provenance.